Abstract
To develop cancer electrochemical treatment (ECT) in the United States, we have conducted basic studies and started a Phase I clinical trial. Our in vivo preliminary results indicate that ECT is effective on RIF-1 mouse tumor and rat fibrosarcomas. In the in vitro study ECT clearly demonstrated dose-dependent human oral carcinoma KB cell growth inhibition by colony-forming assay. We have started an animal study to resolve the ECT methodological problems for rat breast cancer. Meanwhile, we began a clinical trial treating patients with recurrent superficial measurable malignant tumors. Our goal is to make ECT a useful alternative method for treating localized tumors.
Original language | English |
---|---|
Title of host publication | Proceedings of the International Conference on Bioelectromagnetism |
Publisher | IEEE |
Pages | 19-20 |
Number of pages | 2 |
Publication status | Published - 1998 |
Externally published | Yes |
Event | Proceedings of the 1998 2nd International Conference on Bioelectromagnetism - Melbourne, Australia Duration: Feb 15 1998 → Feb 18 1998 |
Other
Other | Proceedings of the 1998 2nd International Conference on Bioelectromagnetism |
---|---|
City | Melbourne, Australia |
Period | 2/15/98 → 2/18/98 |
ASJC Scopus subject areas
- General Engineering